Nephritic Hematuria - Causes, Treatment & When to See a Doctor

What is Nephritic Hematuria?

Nephritic hematuria refers to the presence of red blood cells in the urine that originates from inflammation of the kidney’s filtering units (the glomeruli). It is a hallmark of the nephritic syndrome, a group of disorders characterized by glomerular inflammation, reduced kidney function, and often accompanying protein loss. Unlike “post‑renal” sources of blood (e.g., bladder or urethral injury), nephritic hematuria originates inside the kidney and is usually “microscopic” (detectable only on a dipstick or microscopy) but can also be gross (visible to the eye) when the bleeding is heavy.

Understanding nephritic hematuria matters because it may signal an acute or chronic kidney disease that, if left untreated, can progress to permanent loss of kidney function. Early recognition, evaluation, and treatment improve outcomes and can prevent long‑term complications.

Common Causes

The following conditions are the most frequent culprits of nephritic hematuria. Many are immune‑mediated, highlighting the importance of a detailed medical history and laboratory work‑up.

• IgA Nephropathy (Berger disease) – The most common primary glomerulonephritis worldwide; presents with episodic hematuria often after an upper‑respiratory infection.
• Post‑Infectious Glomerulonephritis (PIGN) – Typically follows streptococcal throat or skin infection; also linked to other bacteria (Staphylococcus, Legionella) and viruses.
• Lupus Nephritis – Kidney involvement in systemic lupus erythematosus, often presenting with both hematuria and proteinuria.
• Membranoproliferative Glomerulonephritis (MPGN) – Can be idiopathic or secondary to infections, hepatitis C, or complement dysregulation.
• ANCA‑Associated Vasculitis (e.g., Granulomatosis with polyangiitis, Microscopic polyangiitis) – Small‑vessel inflammation causing rapidly progressive glomerulonephritis.
• Goodpasture Syndrome – Autoantibodies target the basement membrane of both kidneys and lungs; presents with hematuria and pulmonary hemorrhage.
• Alport Syndrome – Genetic defect in type IV collagen, leading to thinning of the glomerular basement membrane and hematuria from childhood.
• Complement‑mediated Kidney Diseases (e.g., C3 glomerulopathy) – Abnormal activation of the complement pathway damages the glomeruli.
• Infective Endocarditis–related Glomerulonephritis – Immune‑complex deposition secondary to bacterial heart valve infection.
• Drug‑Induced Nephritis – Certain antibiotics (penicillins, cephalosporins), non‑steroidal anti‑inflammatory drugs (NSAIDs), and proton‑pump inhibitors can trigger an immune reaction in the glomeruli.

Associated Symptoms

Nephritic hematuria rarely appears in isolation. Look for other signs that suggest glomerular inflammation or declining kidney function:

• Dark, tea‑colored or cola‑colored urine (gross hematuria)
• Proteinuria – often measured as 1–3 g per 24 h (subnephrotic range)
• Edema – swelling of the face, ankles, or feet due to fluid retention
• Hypertension – new or worsening high blood pressure
• Oliguria – reduced urine output (< 400 mL/24 h)
• Painful flank sensations or a dull ache in the lower back
• Fever, malaise, or recent sore throat/skin infection – clues to a post‑infectious cause
• Systemic features such as rash, joint pains, or lung symptoms (cough, shortness of breath) in systemic vasculitis or lupus.

When to See a Doctor

Because nephritic hematuria can herald progressive kidney injury, prompt medical attention is essential when any of the following occur:

• Visible blood in urine that does not disappear within 24–48 hours.
• Accompanying symptoms such as swelling, high blood pressure, or decreased urine output.
• Recent infection (e.g., strep throat, impetigo) followed by a change in urine color.
• History of autoimmune disease (lupus, vasculitis) or a family history of kidney disease.
• Persistent proteinuria on a home dip‑stick test (≥ 1+).
• Any new, unexplained weight gain or shortness of breath suggesting fluid overload.

If you have any of these concerns, schedule an appointment with a primary‑care physician or a nephrologist. Early evaluation can halt disease progression.

Diagnosis

Diagnosing the underlying cause of nephritic hematuria requires a systematic approach that combines history, physical examination, laboratory studies, and imaging. Below is a step‑by‑step overview.

Laboratory Tests

• Urinalysis with microscopy – detects red blood cell casts (pathognomonic for glomerular bleeding), protein, and cellular debris.
• Quantitative protein measurement – 24‑hour urine protein or spot urine protein‑to‑creatinine ratio.
• Serum creatinine & eGFR – assesses kidney function.
• Complement levels (C3, C4) – low C3 suggests post‑infectious or complement‑mediated GN.
• Autoantibody panels – ANA, anti‑dsDNA (lupus), ANCA, anti‑GBM (Goodpasture).
• Streptococcal serologies – ASO titer or anti‑DNAse B for recent infection.
• Infectious work‑up – blood cultures, hepatitis B/C serologies, HIV testing if risk factors present.

Imaging

• Renal ultrasound – evaluates kidney size, obstruction, and cortical thickness.
• CT or MRI – reserved for complex cases where structural lesions are suspected.

Kidney Biopsy

When non‑invasive testing cannot pinpoint the etiology, a percutaneous renal biopsy is the gold standard. Light microscopy, immunofluorescence, and electron microscopy together reveal the pattern of injury (e.g., immune‑complex deposition, crescents, basement‑membrane abnormalities) and guide targeted therapy.

Treatment Options

Treatment is individualized, aiming to control inflammation, preserve kidney function, and manage complications such as hypertension and fluid overload. The following categories cover most therapeutic approaches.

General Measures

• Control blood pressure – target <130/80 mm Hg using ACE inhibitors or ARBs, which also reduce proteinuria.
• Reduce sodium intake (<2 g/day) to limit edema and hypertension.
• Maintain adequate hydration, but avoid excessive fluid overload, especially if oliguria is present.
• Stop potentially nephrotoxic agents (NSAIDs, high‑dose antibiotics, contrast dyes).

Immunosuppressive Therapy

• Corticosteroids – high‑dose prednisone (0.5‑1 mg/kg/day) is first‑line for many proliferative GN (e.g., IgA, lupus).
• Cytotoxic agents – cyclophosphamide, azathioprine, or mycophenolate mofetil for severe or rapidly progressive disease.
• Rituximab – B‑cell depleting therapy useful in ANCA‑associated vasculitis and certain refractory cases.
• Plasmapheresis – indicated for Goodpasture syndrome or severe ANCA vasculitis with pulmonary hemorrhage.

Specific Treatments Based on Cause

• Post‑infectious GN – mostly supportive; antibiotics for the underlying infection and close monitoring; steroids rarely needed.
• Lupus nephritis – combination of steroids + mycophenolate or cyclophosphamide, plus hydroxychloroquine.
• Complement‑mediated GN – eculizumab (a C5 inhibitor) approved for atypical hemolytic uremic syndrome and some C3 glomerulopathies.
• Alport syndrome – no cure; ACE inhibitors/ARBs delay progression; eventual renal replacement therapy may be required.

Kidney‑Replacement Therapy

If kidney function declines to an eGFR <15 mL/min/1.73 m² or patients develop refractory fluid/electrolyte problems, dialysis (hemodialysis or peritoneal) or transplant evaluation becomes necessary.

Prevention Tips

While not all causes are preventable, several strategies can lessen the risk of developing nephritic hematuria or its complications.

• Promptly treat streptococcal throat or skin infections with appropriate antibiotics.
• Maintain good hygiene and infection control to reduce exposure to hepatitis B/C, HIV, and other pathogens.
• Avoid unnecessary NSAID use; use acetaminophen for pain when possible.
• Control modifiable risk factors for autoimmune disease flares – stress management, smoking cessation, and regular follow‑up for known conditions (e.g., lupus).
• Vaccinate against influenza, pneumococcus, hepatitis B, and COVID‑19; infections can trigger immune‑complex GN.
• Stay hydrated but respect fluid restrictions if you have underlying CKD.
• Regularly monitor blood pressure and proteinuria if you have a known kidney disorder.

Emergency Warning Signs

Key Take‑aways

Nephritic hematuria is a red flag that the kidneys’ filtering structures are inflamed. It can stem from a wide array of immune‑mediated or infectious conditions. Early recognition, thorough evaluation, and cause‑specific therapy dramatically improve the chance of preserving kidney function. If you notice blood in your urine—especially when accompanied by swelling, high blood pressure, or reduced urine output—contact a healthcare professional promptly.

References:

• Mayo Clinic. “Hematuria: Causes, diagnosis, and treatment.” 2023.
• National Kidney Foundation. “Glomerulonephritis.” Updated 2022.
• CDC. “Post‑streptococcal glomerulonephritis.” 2021.
• Cleveland Clinic. “IgA Nephropathy.” 2023.
• Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for Glomerulonephritis, 2021.
• Riffat S, et al. “Management of ANCA‑associated vasculitis.” NEJM. 2022;386:2549‑2561.